Cargando…
Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention
Despite decades of research, ovarian cancer is still associated with unacceptably high mortality rates, which must be addressed by novel therapeutic approaches. One avenue through which this may be achieved is targeting of tumor-initiating ‘Cancer Stem Cells’ (CSCs). CSCs are sufficient to generate...
Autores principales: | Ffrench, Brendan, Gasch, Claudia, O’Leary, John J, Gallagher, Michael F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295405/ https://www.ncbi.nlm.nih.gov/pubmed/25495823 http://dx.doi.org/10.1186/1476-4598-13-262 |
Ejemplares similares
-
Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention
por: Gasch, Claudia, et al.
Publicado: (2017) -
MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype
por: Lynam-Lennon, Niamh, et al.
Publicado: (2016) -
CD10(−)/ALDH(−) cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy
por: Ffrench, Brendan, et al.
Publicado: (2017) -
Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
por: MacDonagh, Lauren, et al.
Publicado: (2017) -
Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samples
por: Gallagher, Michael F, et al.
Publicado: (2012)